Overview

A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)

Status:
Unknown status

Trial end date:
2019-12-26

Target enrollment:

Participant gender:

Summary

Comparative randomized, single dose, three periods, three-way crossover open-label study to determine the bioequivalence of Valsartan and Amlodipine Tablets (Hua yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland).

Phase:

Phase 1

Details

Lead Sponsor:

Second Affiliated Hospital of Wenzhou Medical University

Treatments:

Amlodipine
Amlodipine, Valsartan Drug Combination
Valsartan